W-84 dibromide

CAS No. 21093-51-6

W-84 dibromide( HDMPPA )

Catalog No. M23959 CAS No. 21093-51-6

W-84 dibromide is a M2-receptor selective modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 28 In Stock
5MG 44 In Stock
10MG 69 In Stock
25MG 150 In Stock
50MG 239 In Stock
100MG 356 In Stock
200MG 507 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    W-84 dibromide
  • Note
    Research use only, not for human use.
  • Brief Description
    W-84 dibromide is a M2-receptor selective modulator.
  • Description
    W-84 dibromide is a M2-receptor selective modulator.
  • In Vitro
    The stabilizing effect of W-84 (dibromide) on antagonist-receptor complexes may explain the overadditive protective action exerted by the combination of atropine and W-84 (dibromide) against organophosphate intoxication. W-84 (dibromide) not only inhibits radioligand association but also strongly stabilizes antagonist-receptor complexes.
  • In Vivo
    ——
  • Synonyms
    HDMPPA
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    M2 mAChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21093-51-6
  • Formula Weight
    708.52
  • Molecular Formula
    C32H44Br2N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:7mg/ml(9.88mM; need ultrasonic)
  • SMILES
    O=C1N(C(C2=CC=CC=C12)=O)CCC[N+](C)(C)CCCCCC[N+](C)(C)CCCN(C3=O)C(C4=CC=CC=C34)=O.[Br-].[Br-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JHU 37152

    JHU 37152 is a Designer Receptors Exclusively Activated by Designer Drug (DREADD) agonist with Ki of 1.8 nM and 8.7 nM for human muscarinic acetylcholine M3 receptors (hM3Dq) and hM4Di in vitro, respectively.?

  • Pirenzepine dihydroc...

    An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function.

  • BMS-303141

    BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL).